Neurology News: Breaking Neurology News, Comments and Articles. - Page: 2

Rosellini Scientific Hires Chuck Schwandt, VP of Business Development

Dallas, TX, May 22, 2013 --(PR.com)-- Rosellini Scientific, LLC is pleased to announce the recent hire of Chuck Schwandt as Vice President of Business Development. Chuck is adding his twenty-plus years of leadership, service, and sales experience to the Rosellini Scientific team. Chuck called GE Healthcare home for over 10 years excelling in roles such as Commercial Manager, National Service Acco...

[Comment] From mice to man: chloride transport in leukoencephalopathy

In The Lancet Neurology, Christel Depienne and colleagues show that mutations in CLCN2—the gene encoding the chloride channel ClC-2—underlie a specific form of human leukoencephalopathy. This important work confirms in human beings what was previ...

[Comment] Presymptomatic features of spinocerebellar ataxias

Although more than 30 genetically distinct forms of dominant progressive spinocerebellar ataxia (SCA) are now recognised, more than half of all families affected by SCAs have SCA1, SCA2, SCA3, or SCA6. All these forms are characterised by expanded po...

Oxygenation Targets and Outcomes in Premature Infants Oxygenation Targets and Outcomes in Premature Infants

Many premature infants experience respiratory failure and receive supplemental oxygen for prolonged periods. While this therapy is crucial for their survival, it can be associated with complications such as retinopathy of prematurity (ROP), bronchopu...

Top International Neuroscience Clinicians, Scientists, Industry Leaders Collaborate at Third Annual Targeted Drug Delivery Conference in San Francisco

NAPA, CA -- (Marketwired) -- 05/22/13 -- The world's top minds in medicine, science and business convened in San Francisco for the Third Annual Targeted Drug Delivery Conference. The conference provides a venue to stimulate collaboration on innovative treatments for patients suffering from neurological diseases such as Parkinson's, Alzheimer's and chronic pain. Direct delivery of therapies using...

Testing Diabetes Drug On Parkinson's Disease Patients

Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the progression of the disease....

Ironwood Pharmaceuticals Prices Public Offering of Common Stock

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the pricing of an underwritten public offering of 10,500,000 shares of its Class A common stock at a price of $13.00 per share to the public. All of the shares are being offered by Ironwood. The gross proceeds to Ironwood from this offering are expected to be approximately $136.5 million,...

Parents: Help Your Teens Party Right at Graduation

BETHESDA, Md., May 20, 2013 /PRNewswire/ -- Graduation…Graduation is a time to celebrate. But before the party starts, take the time to talk with your graduates about alcohol -- it just may save a life. (Photo:  http://photos.prnewswire.com/prnh/20130520/PH16605-INFO) It's About Your Teen…A teenager's brain is still developing and it is very sensitive to alcohol's effects on ju...

Valeant Pharmaceuticals Announces 2013 Annual Meeting Results

LAVAL, Quebec, May 21, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of ten directors nominated at its 2013 annual meeting of shareholders today.  The detailed results of the vote for the election of directors are set out below:  Name For Withheld

Mediterranean Diet Offers Cognitive Boost To The Aging Brain

Peter Suciu for redOrbit.com – Your Universe Online The Mayo Clinic has called the Mediterranean diet a heart-healthy eating plan as it combines elements of Mediterranean-style cooking with a splash of flavorful olive oil. The diet has also has been credited with lowering cholesterol in men, even among those who don’t lose weight. Now researchers have again shown that the Mediterranean diet...

Gene therapy at center of UTMB effort to eliminate neuropathic pain

University of Texas Medical Branch at Galveston researchers have been awarded a five-year, $1.8 million grant by the National Institute of Neurological Disorders and Stroke to apply the techniques of gene therapy to the problem of neuropathic pain—...

AAG Health is the First Age Management Center in Florida to Offer the OligoScan

The OligoScan is the latest addition to AAG Health’s line-up of state-of-the-art diagnostic testing devices which already include the research grade InBody 720 (body composition analyzer), the Korr MetaCheck (resting metabolic rate machine), the Panasonic Cardio Heart Station (arterial plaque analyzer) and the Biomarkers of Aging testing series. Miami, Florida (PRWEB) May 21, 2013 AAG Health, t...

FDA Review Staff Look Into Efficacy Of High Dose Sleep Drug

Lawrence LeBlond for redOrbit.com - Your Universe Online An experimental insomnia drug from Merck & Co has been shown to be effective, but reviewers with the US Food and Drug Administration (FDA) are questioning the drug’s dosage levels. The comments, posted on the agency’s website Monday, come ahead of a meeting of external medical experts which will advise on whether the drug, called su...

UTMB researchers awarded grant to study gene therapy techniques to eliminate neuropathic pain

University of Texas Medical Branch at Galveston researchers have been awarded a five-year, $1.8 million grant by the National Institute of Neurological Disorders and Stroke to apply the techniques of gene therapy to the problem of neuropathic pain -...

Multiple Target ALS Drug Ready for Genervon's Phase 2 Trial

Multiple targets, highly effective, breakthrough therapy for ALS sufferers may now be within reach. Winston Ko, the CEO of Genervon Biopharmaceuticals, will be presenting on Friday at the Neurotech Conference in San Francisco that its endogenous regulatory drug GM604 modulates over 80 ALS related gene targets interactively and dynamically through 12 pathwa...

Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that it has commenced an underwritten public offering of 10,500,000 shares of its Class A common stock. All of the shares are being offered by Ironwood. The Company will grant the underwriters a 30-day option to purchase up to an additional 1,575,000 shares in connection with the offering....

ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the completion of an underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant to the full exercise of an option to purchase additional shares previously granted to the underwriters. All of the shares were offered by ACADIA at a price to the publ...

Mediterranean diet seems to boost ageing brain power

A Mediterranean diet with added extra virgin olive oil or mixed nuts seems to improve the brain power of older people better than advising them to follow a low-fat diet, indicates research published online in the Journal of Neurology Neurosurgery and...

Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference

LAVAL, Quebec, May 20, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the 34th Annual Goldman Sachs Healthcare Conference on Tuesday, June 11, 2013 at 9:20 a.m. PT. The conference will be held at the Terranea Resort in Los Angeles, CA. A live webcast and audio ar...

The Truth 365 Childhood Cancer Documentary Receives Three Emmy® Nominations from the National Academy of Television Arts and Sciences

The Documentary Received Two Nominations for Outstanding Individual Achievement in a Craft Baltimore, Maryland (PRWEB) May 20, 2013 The Truth 365, a documentary about childhood cancer, received three Emmy® nominations from the National Academy of Television Arts and Sciences. The Emmy® Awards Gala will be held at the Baltimore Marriott Waterfront in Baltimore, MD on Saturday, June 15, 2...

USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss

NEW YORK, May 20, 2013 /PRNewswire-iReach/ -- It is no secret that Americans have an obesity problem. With more than one third being overweight or obese gyms and supplement companies are in line to make massive profits. Most of the time the condition is primarily related to dietary issues and a lack of physical activity but on occasion it can be the result of a glandular problem or even a vitamin...

Dr. Sanusi Umar Awarded RealSelf 100 for Excellence in Patient Education

RealSelf.com names dermatologic surgeon Dr. Sanusi Umar among its top 100 medical contributors out of 5,000. The honor recognizes physicians for their ongoing contribution to the education of patients and the progression of online healthcare resources. (PRWEB) May 20, 2013 Dr. Sanusi Umar, of the Redondo Beach-based FineTouch Dermatology, has been recognized as a top doctor by RealSelf.com. The R...

Multiple System Atrophy (MSA) Research Grant Program Announced

The Multiple System Atrophy Coalition launches its new MSA Research Grant program, including the creation of a world-class Scientific Advisory Board and Advocate Research Committee to review research proposals and recommend grants. Raleigh, NC (PRWEB) May 20, 2013 The Multiple System Atrophy Coalition (formerly the SDS/MSA Support Group) announced today the launch of its new Multiple System Atrop...

Upsher-Smith Introduces Newly Redesigned Corporate Website

MAPLE GROVE, Minn., May 20, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., a specialty pharmaceutical company committed to the development of new treatments for diseases of the central nervous system, today announced the launch of its newly designed website, upsher-smith.com. The new site celebrates life's moments through images and narratives.  As part of the company's mission st...

ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: ^NBI) effective prior to today’s market open. The NASDA...